FDA Sends Untitled Letter to Novo Nordisk Over Wegovy Television Advertisement
Novo Nordisk A/S has acknowledged receipt of an "untitled letter" from the U.S. Food and Drug Administration concerning a television commercial for its Wegovy pill. The company says it is preparing a response to address the FDA's concerns but has not disclosed details about the alleged issues or the creative content at the center of the agency's in…